Testing effectiveness (Phase 2)Ended earlyNCT00050687
What this trial is testing
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
Who this might be right for
Prostatic NeoplasmsMultiple MyelomaBladder Neoplasms+1 more
Titan Pharmaceuticals